CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
3.720
+0.080 (2.20%)
At close: Jul 26, 2024, 4:00 PM
3.760
+0.040 (1.08%)
After-hours: Jul 26, 2024, 6:49 PM EDT
CureVac Market Cap
CureVac has a market cap or net worth of $834.42 million as of July 26, 2024. Its market cap has decreased by -62.65% in one year.
Market Cap
834.42M
Enterprise Value
548.57M
1-Year Change
-62.65%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $2.82B to $834.42M, a decrease of -70.45%. That is a compound annual growth rate of -26.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 816.50M | -13.39% |
| Dec 29, 2023 | 942.70M | -17.84% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 406.69% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perspective Therapeutics | 853.66M |
| Mesoblast | 846.41M |
| Olema Pharmaceuticals | 836.21M |
| Standard BioTools | 835.30M |
| InnovAge Holding | 834.97M |
| Nuvation Bio | 823.50M |
| Erasca | 818.51M |
| Cytek Biosciences | 816.52M |